Loading…

Production, applications and status of zirconium-89 immunoPET agents

Zirconium-89 has attracted huge interests and is used in tracing and quantification of slow biological processes and labeling of long half-live biomolecules such as monoclonal antibodies for pharmacokinetic studies and clinical trials. In this review, a concise introduction to targetry, irradiation...

Full description

Saved in:
Bibliographic Details
Published in:Journal of radioanalytical and nuclear chemistry 2017-10, Vol.314 (1), p.7-21
Main Authors: Jalilian, Amir R., Osso, Joao Alberto
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c383t-2ad607de4fb5aa1a0fbdf6f4d6e6604fafc4ec32eca62182e9c6847325f9c2ef3
cites cdi_FETCH-LOGICAL-c383t-2ad607de4fb5aa1a0fbdf6f4d6e6604fafc4ec32eca62182e9c6847325f9c2ef3
container_end_page 21
container_issue 1
container_start_page 7
container_title Journal of radioanalytical and nuclear chemistry
container_volume 314
creator Jalilian, Amir R.
Osso, Joao Alberto
description Zirconium-89 has attracted huge interests and is used in tracing and quantification of slow biological processes and labeling of long half-live biomolecules such as monoclonal antibodies for pharmacokinetic studies and clinical trials. In this review, a concise introduction to targetry, irradiation data, separation and coordination chemistry of zirconium-89 has been presented. A detailed overreviwew on bi-functional ligands conjugation and 89 Zr radiolabeling been addressed. The latest status of preclinical as well as clinical trials using 89 Zr radioimmunomolecules in various human diseases has been presented since 2012.
doi_str_mv 10.1007/s10967-017-5358-z
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_1941739467</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A506098506</galeid><sourcerecordid>A506098506</sourcerecordid><originalsourceid>FETCH-LOGICAL-c383t-2ad607de4fb5aa1a0fbdf6f4d6e6604fafc4ec32eca62182e9c6847325f9c2ef3</originalsourceid><addsrcrecordid>eNp1kctKAzEUhoMoWKsP4G7Aram5zCSZZalXKNhFXYc0k5SUTjImMwv79KaMoIISOOEc_u9c-AG4xmiGEeJ3CaOacYgwhxWtBDycgAmuhICEC3QKJohQBitO8Tm4SGmHEKqFoBNwv4qhGXTvgr8tVNftnVbHJBXKN0XqVT-kItji4KIO3g0tFHXh2nbwYfWwLtTW-D5dgjOr9slcff1T8Pb4sF48w-Xr08tivoSaCtpDohqGeGNKu6mUwgrZTWOZLRtmGEOlVVaXRlNitGIEC2JqzUTJKalsrYmxdApuxr5dDO-DSb3chSH6PFLiusSc1iXj36qt2hvpvA19VLp1Sct5hVg-PMesmv2hyq8xrcunGuty_ReAR0DHkFI0VnbRtSp-SIzk0QM5eiCzB_LogTxkhoxMylq_NfHHwv9Cn5UZiUU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1941739467</pqid></control><display><type>article</type><title>Production, applications and status of zirconium-89 immunoPET agents</title><source>Springer Nature:Jisc Collections:Springer Nature Read and Publish 2023-2025: Springer Reading List</source><creator>Jalilian, Amir R. ; Osso, Joao Alberto</creator><creatorcontrib>Jalilian, Amir R. ; Osso, Joao Alberto</creatorcontrib><description>Zirconium-89 has attracted huge interests and is used in tracing and quantification of slow biological processes and labeling of long half-live biomolecules such as monoclonal antibodies for pharmacokinetic studies and clinical trials. In this review, a concise introduction to targetry, irradiation data, separation and coordination chemistry of zirconium-89 has been presented. A detailed overreviwew on bi-functional ligands conjugation and 89 Zr radiolabeling been addressed. The latest status of preclinical as well as clinical trials using 89 Zr radioimmunomolecules in various human diseases has been presented since 2012.</description><identifier>ISSN: 0236-5731</identifier><identifier>EISSN: 1588-2780</identifier><identifier>DOI: 10.1007/s10967-017-5358-z</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Biological activity ; Biomolecules ; Chemistry ; Chemistry and Materials Science ; Clinical trials ; Conjugation ; Diagnostic Radiology ; Hadrons ; Heavy Ions ; Inorganic Chemistry ; Medical research ; Monoclonal antibodies ; Nuclear Chemistry ; Nuclear Physics ; Nuclear reactors ; Pharmacology ; Physical Chemistry ; Positron emission tomography ; Radiation (Physics) ; Zirconium</subject><ispartof>Journal of radioanalytical and nuclear chemistry, 2017-10, Vol.314 (1), p.7-21</ispartof><rights>Akadémiai Kiadó, Budapest, Hungary 2017</rights><rights>COPYRIGHT 2017 Springer</rights><rights>Copyright Springer Science &amp; Business Media 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c383t-2ad607de4fb5aa1a0fbdf6f4d6e6604fafc4ec32eca62182e9c6847325f9c2ef3</citedby><cites>FETCH-LOGICAL-c383t-2ad607de4fb5aa1a0fbdf6f4d6e6604fafc4ec32eca62182e9c6847325f9c2ef3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Jalilian, Amir R.</creatorcontrib><creatorcontrib>Osso, Joao Alberto</creatorcontrib><title>Production, applications and status of zirconium-89 immunoPET agents</title><title>Journal of radioanalytical and nuclear chemistry</title><addtitle>J Radioanal Nucl Chem</addtitle><description>Zirconium-89 has attracted huge interests and is used in tracing and quantification of slow biological processes and labeling of long half-live biomolecules such as monoclonal antibodies for pharmacokinetic studies and clinical trials. In this review, a concise introduction to targetry, irradiation data, separation and coordination chemistry of zirconium-89 has been presented. A detailed overreviwew on bi-functional ligands conjugation and 89 Zr radiolabeling been addressed. The latest status of preclinical as well as clinical trials using 89 Zr radioimmunomolecules in various human diseases has been presented since 2012.</description><subject>Biological activity</subject><subject>Biomolecules</subject><subject>Chemistry</subject><subject>Chemistry and Materials Science</subject><subject>Clinical trials</subject><subject>Conjugation</subject><subject>Diagnostic Radiology</subject><subject>Hadrons</subject><subject>Heavy Ions</subject><subject>Inorganic Chemistry</subject><subject>Medical research</subject><subject>Monoclonal antibodies</subject><subject>Nuclear Chemistry</subject><subject>Nuclear Physics</subject><subject>Nuclear reactors</subject><subject>Pharmacology</subject><subject>Physical Chemistry</subject><subject>Positron emission tomography</subject><subject>Radiation (Physics)</subject><subject>Zirconium</subject><issn>0236-5731</issn><issn>1588-2780</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp1kctKAzEUhoMoWKsP4G7Aram5zCSZZalXKNhFXYc0k5SUTjImMwv79KaMoIISOOEc_u9c-AG4xmiGEeJ3CaOacYgwhxWtBDycgAmuhICEC3QKJohQBitO8Tm4SGmHEKqFoBNwv4qhGXTvgr8tVNftnVbHJBXKN0XqVT-kItji4KIO3g0tFHXh2nbwYfWwLtTW-D5dgjOr9slcff1T8Pb4sF48w-Xr08tivoSaCtpDohqGeGNKu6mUwgrZTWOZLRtmGEOlVVaXRlNitGIEC2JqzUTJKalsrYmxdApuxr5dDO-DSb3chSH6PFLiusSc1iXj36qt2hvpvA19VLp1Sct5hVg-PMesmv2hyq8xrcunGuty_ReAR0DHkFI0VnbRtSp-SIzk0QM5eiCzB_LogTxkhoxMylq_NfHHwv9Cn5UZiUU</recordid><startdate>20171001</startdate><enddate>20171001</enddate><creator>Jalilian, Amir R.</creator><creator>Osso, Joao Alberto</creator><general>Springer Netherlands</general><general>Springer</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20171001</creationdate><title>Production, applications and status of zirconium-89 immunoPET agents</title><author>Jalilian, Amir R. ; Osso, Joao Alberto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c383t-2ad607de4fb5aa1a0fbdf6f4d6e6604fafc4ec32eca62182e9c6847325f9c2ef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Biological activity</topic><topic>Biomolecules</topic><topic>Chemistry</topic><topic>Chemistry and Materials Science</topic><topic>Clinical trials</topic><topic>Conjugation</topic><topic>Diagnostic Radiology</topic><topic>Hadrons</topic><topic>Heavy Ions</topic><topic>Inorganic Chemistry</topic><topic>Medical research</topic><topic>Monoclonal antibodies</topic><topic>Nuclear Chemistry</topic><topic>Nuclear Physics</topic><topic>Nuclear reactors</topic><topic>Pharmacology</topic><topic>Physical Chemistry</topic><topic>Positron emission tomography</topic><topic>Radiation (Physics)</topic><topic>Zirconium</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jalilian, Amir R.</creatorcontrib><creatorcontrib>Osso, Joao Alberto</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of radioanalytical and nuclear chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jalilian, Amir R.</au><au>Osso, Joao Alberto</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Production, applications and status of zirconium-89 immunoPET agents</atitle><jtitle>Journal of radioanalytical and nuclear chemistry</jtitle><stitle>J Radioanal Nucl Chem</stitle><date>2017-10-01</date><risdate>2017</risdate><volume>314</volume><issue>1</issue><spage>7</spage><epage>21</epage><pages>7-21</pages><issn>0236-5731</issn><eissn>1588-2780</eissn><abstract>Zirconium-89 has attracted huge interests and is used in tracing and quantification of slow biological processes and labeling of long half-live biomolecules such as monoclonal antibodies for pharmacokinetic studies and clinical trials. In this review, a concise introduction to targetry, irradiation data, separation and coordination chemistry of zirconium-89 has been presented. A detailed overreviwew on bi-functional ligands conjugation and 89 Zr radiolabeling been addressed. The latest status of preclinical as well as clinical trials using 89 Zr radioimmunomolecules in various human diseases has been presented since 2012.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><doi>10.1007/s10967-017-5358-z</doi><tpages>15</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0236-5731
ispartof Journal of radioanalytical and nuclear chemistry, 2017-10, Vol.314 (1), p.7-21
issn 0236-5731
1588-2780
language eng
recordid cdi_proquest_journals_1941739467
source Springer Nature:Jisc Collections:Springer Nature Read and Publish 2023-2025: Springer Reading List
subjects Biological activity
Biomolecules
Chemistry
Chemistry and Materials Science
Clinical trials
Conjugation
Diagnostic Radiology
Hadrons
Heavy Ions
Inorganic Chemistry
Medical research
Monoclonal antibodies
Nuclear Chemistry
Nuclear Physics
Nuclear reactors
Pharmacology
Physical Chemistry
Positron emission tomography
Radiation (Physics)
Zirconium
title Production, applications and status of zirconium-89 immunoPET agents
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T03%3A20%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Production,%20applications%20and%20status%20of%20zirconium-89%20immunoPET%20agents&rft.jtitle=Journal%20of%20radioanalytical%20and%20nuclear%20chemistry&rft.au=Jalilian,%20Amir%20R.&rft.date=2017-10-01&rft.volume=314&rft.issue=1&rft.spage=7&rft.epage=21&rft.pages=7-21&rft.issn=0236-5731&rft.eissn=1588-2780&rft_id=info:doi/10.1007/s10967-017-5358-z&rft_dat=%3Cgale_proqu%3EA506098506%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c383t-2ad607de4fb5aa1a0fbdf6f4d6e6604fafc4ec32eca62182e9c6847325f9c2ef3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1941739467&rft_id=info:pmid/&rft_galeid=A506098506&rfr_iscdi=true